Psychological aspects of premenstrual syndrome

被引:41
作者
Indusekhar, Radha [1 ]
Usman, Sa'adatu Bose [1 ]
O'Brien, Shaughn [1 ]
机构
[1] Univ Hosp N Staff, Acad Unit, Stoke On Trent ST4 6QG, Staffs, England
关键词
premenstrual syndrome; PMS; premenstrual dysphoric disorder; psychological disorders; serotonin; selective serotonin re-uptake inhibitors (SSRIs); menstrual disorders; RANDOMIZED-CONTROLLED-TRIAL; DYSPHORIC DISORDER; LUTEAL-PHASE; MENSTRUAL-CYCLE; CROSSOVER TRIAL; SEXUAL-ABUSE; DOUBLE-BLIND; WOMEN; SYMPTOMS; EFFICACY;
D O I
10.1016/j.bpobgyn.2006.10.002
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Premenstrual syndrome (PMS) is a group of psychological and physical symptoms which regularly occur during the luteal phase of the menstrual cycle and resolve by the end of menstruation. The severe and predominantly psychological form of PMS is called premenstrual dysphoric disorder (PMDD). The exact aetiology of PMS is not known. PMS results from ovulation and appears to be caused by the progesterone produced following ovulation in women who have enhanced sensitivity to this progesterone. The increased sensitivity may be due to neurotransmitter (mainly serotonin) dysfunction. The key diagnostic feature is that the symptoms must be absent in the time between the end of menstruation and ovulation. Prospective symptom rating charts are used for this purpose. Treatment is achieved by suppression of ovulation or reducing progesterone sensitivity with selective serotonin re-uptake inhibitors. In this chapter, the authors describe the aetiology, symptoms, diagnosis and evidence-based management of premenstrual syndrome.
引用
收藏
页码:207 / 220
页数:14
相关论文
共 67 条
  • [1] [Anonymous], 1994, AM PSYCHIATR ASSOC
  • [2] ALTERATION OF PLATELET SEROTONERGIC MECHANISMS AND MONOAMINE-OXIDASE ACTIVITY IN PREMENSTRUAL-SYNDROME
    ASHBY, CR
    CARR, LA
    COOK, CL
    STEPTOE, MM
    FRANKS, DD
    [J]. BIOLOGICAL PSYCHIATRY, 1988, 24 (02) : 225 - 233
  • [3] Backström T, 2003, CNS DRUGS, V17, P325
  • [4] BACKSTROM T, 2006, GYNAECOLOGY FORUM, V11, P20
  • [5] Neurosteroids and reward: allopregnanolone produces a conditioned place aversion in rats
    Beauchamp, MH
    Ormerod, BK
    Jhamandas, K
    Boegman, RJ
    Beninger, RJ
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2000, 67 (01) : 29 - 35
  • [6] BIBI KW, 1995, DISS ABSTR INT, V56, P6678
  • [7] Allopregnanolone in women with premenstrual syndrome
    Bicíková, M
    Dibbelt, L
    Hill, M
    Hampl, R
    Stárka, L
    [J]. HORMONE AND METABOLIC RESEARCH, 1998, 30 (04) : 227 - 229
  • [8] SEROTONIN RECEPTOR CONCENTRATION DURING THE ESTROUS-CYCLE OF THE RAT
    BIEGON, A
    BERCOVITZ, H
    SAMUEL, D
    [J]. BRAIN RESEARCH, 1980, 187 (01) : 221 - 225
  • [9] Increase of estrogen dose deteriorates mood during progestin phase in sequential hormonal therapy
    Björn, I
    Sundström-Poromaa, IS
    Bixo, M
    Nyberg, S
    Bäckström, G
    Bäckström, T
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (05) : 2026 - 2030
  • [10] Cognitive therapy for premenstrual syndrome: A controlled trial
    Blake, F
    Salkovskis, P
    Gath, D
    Day, A
    Garrod, A
    [J]. JOURNAL OF PSYCHOSOMATIC RESEARCH, 1998, 45 (04) : 307 - 318